Pharm
Niacin
search
Niacin
, Nicotinic Acid, Niacinamide, Vitamin B3, Simcor, Advicor, Cordaptive
See Also
Hyperlipidemia
Niacin Deficiency
(
Pellagra
)
Background
Niacin (Nicotinic Acid, Niacinamide, Vitamin B3) is a B
Vitamin
As a component of
NADH
and
NADPH
, is involved in many in vivo reactions
Niacin may be ingested or synthesized from
Tryptophan
(
Essential Amino Acid
)
Food sources of Niacin
Wheat germ
Liver
Fish
Peanuts
Niacin Deficiency
(
Pellagra
)
Sythesized from
Tryptophan
and deficiency may be seen in limited diets (e.g. corn) in which
Tryptophan
is absent
Pellagra
presents with
Diarrhea
, Dermatitis and
Dementia
(3D's)
Indications
Older indications that should be reconsidered in light of AIM-High Study (Niacin did not appear effective in these cases)
Low
HDL Cholesterol
Combination therapy with
Statin
for
Hyperlipidemia
Indications that are reasonable as of 2013
Hypertriglyceridemia
Hyperlipidemia Management
in patients intolerant to
Statin
s
Effects
Lipid
s
HDL increased (15-35%)
No other agent raises HDL as much as Niacin
However Niacin related HDL increase did not effect outcomes in 2011 AIM-HIGH study (prematurely stopped)
Triglyceride
s decreased (20-50%)
LDL Cholesterol
decreased (10-25%)
Significantly lowers LDL only at high dose
Not a first-line agent for lowering LDL
Efficacy
Does not affect all cause mortality
Statin
with Niacin did not show benefit beyond
Statin
alone in AIM-HIGH study (2011)
Studies since the 1980s to today have suggested coronary disease risk reduction, but benefit may be aside from affect on
HDL Cholesterol
Canner (1986) J Am Coll Cardiol, 8:1245 [PubMed]
Lavigne (2013) J Am Coll Cardiol 61(4):440-6. [PubMed]
Adverse effects
Flushing
Pruritus
Skin irritation of neck and face
Gastrointestinal upset (
Dyspepsia
,
Diarrhea
)
Blurred Vision
Fatigue
Glucose
intollerance
Hyperuricemia
and gout
Peptic Ulcer Disease
exacerbation
Hepatic toxicity with sustained release forms
Diabetes Mellitus
(when Niacin is combined with a
Statin
)
Increases risk of developing diabetes or worsening diabetes control
(2014) N Engl J Med 2014 371:203-12 [PubMed]
Adverse Effects
Compliance and tolerance
Poor Compliance: 40% discontinue use
Reduced
Flushing
and
Pruritus
reaction
Use
Aspirin
or
Ibuprofen
pretreatment
Take dose with food
Contraindications
Absolute
Chronic Liver Disease
Severe
Peptic Ulcer Disease
Relative
Type II Diabetes Mellitus
Severe gout
Hyperuricemia
Preparations
Niacin
Crystalline Niacin
Dose: 1g PO tid ($5.50/mo) MAX: 6 g/day
Example protocol (Use 500 mg tablets)
Start: 250 mg at bedtime
Titrate up over 6 weeks to 500 mg tid
Pretreatment:
Aspirin
81 mg before or
Ibuprofen
Niaspan (preferred)
Safest of Niacins (only 4% GI side effects)
More expensive than crystalline Niacin
Example protocol for initiating doses
One 500 mg tablet PO qhs for 1 month
Two 500 mg tablets PO qhs for 1 month
One 1000 mg tablet PO qhs for 1 month
Check lFTs,
Uric Acid
,
Glucose
at 3 months
Two 1000 mg tablets PO qhs
References
McBride (2003) New Therapeutics Lecture, Cable, WI
Agents to avoid
Avoid flush-free or no-flush Niacin
Avoid Slow Niacin (Sustained Release)
Decreased Safety due to hepatotoxicity
Preparations
Niacin combined with other agents
Advicor: Niaspan (500-1000 mg) and
Lovastatin
(20-40 mg)
Simcor: Niaspan (500-1000 mg) and
Simvastatin
(20 mg)
Cordaptive: Niacin (extended release) with Laropiprant (to reduce
Flushing
)
Monitoring
Monitor while checking dose
Glucose
Liver
transaminases
Uric Acid
References
Meyers (2003) Ann Intern Med 139:996-1002 [PubMed]
Last (2011) Am Fam Physician 84(5): 551-8 [PubMed]
Studer (2005) Arch Intern Med 165(7): 725-30 [PubMed]
Sharma (2009) Ann Intern Med 151(9):622-30 [PubMed]
Type your search phrase here